Morepen Laboratories Bilan de santé
Santé financière contrôle des critères 6/6
Morepen Laboratories possède un total de capitaux propres de ₹11.1B et une dette totale de ₹334.9M, ce qui porte son ratio d'endettement à 3%. Son actif total et son passif total sont ₹15.6B et de ₹4.5B. L'EBIT de Morepen Laboratories est ₹1.8B ce qui fait que son ratio de couverture des intérêts 65.5. Elle dispose de liquidités et de placements à court terme de ₹1.9B.
Informations clés
3.0%
Ratio d'endettement
₹334.95m
Dette
| Ratio de couverture des intérêts | 65.5x |
| Argent liquide | ₹1.86b |
| Fonds propres | ₹11.10b |
| Total du passif | ₹4.52b |
| Total des actifs | ₹15.62b |
Mises à jour récentes de la santé financière
Does Morepen Laboratories (NSE:MOREPENLAB) Have A Healthy Balance Sheet?
Jun 13
Morepen Laboratories (NSE:MOREPENLAB) Seems To Use Debt Quite Sensibly
Nov 23Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
Aug 10Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
May 21Morepen Laboratories (NSE:MOREPENLAB) Has A Pretty Healthy Balance Sheet
Jan 03
Recent updates
There's Reason For Concern Over Morepen Laboratories Limited's (NSE:MOREPENLAB) Massive 30% Price Jump
Aug 20Impressive Earnings May Not Tell The Whole Story For Morepen Laboratories (NSE:MOREPENLAB)
Aug 09Improved Earnings Required Before Morepen Laboratories Limited (NSE:MOREPENLAB) Stock's 29% Jump Looks Justified
Jul 05Does Morepen Laboratories (NSE:MOREPENLAB) Have A Healthy Balance Sheet?
Jun 13Morepen Laboratories Limited's (NSE:MOREPENLAB) Popularity With Investors Is Under Threat From Overpricing
Apr 23Morepen Laboratories (NSE:MOREPENLAB) Seems To Use Debt Quite Sensibly
Nov 23Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)
Sep 22Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
Aug 10Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)
Sep 21Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?
Apr 05Do Morepen Laboratories's (NSE:MOREPENLAB) Earnings Warrant Your Attention?
Sep 14Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
May 21Does Morepen Laboratories (NSE:MOREPENLAB) Deserve A Spot On Your Watchlist?
Mar 12Our View On Morepen Laboratories' (NSE:MOREPENLAB) CEO Pay
Feb 22Is Morepen Laboratories Limited's (NSE:MOREPENLAB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Feb 07Morepen Laboratories (NSE:MOREPENLAB) Shareholders Have Enjoyed A 91% Share Price Gain
Jan 21Morepen Laboratories (NSE:MOREPENLAB) Has A Pretty Healthy Balance Sheet
Jan 03Is There More To The Story Than Morepen Laboratories's (NSE:MOREPENLAB) Earnings Growth?
Dec 16Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?
Nov 28Analyse de la situation financière
Passif à court terme: Les actifs à court terme de MOREPENLAB ( ₹10.9B ) dépassent ses passifs à court terme ( ₹4.1B ).
Passif à long terme: Les actifs à court terme de MOREPENLAB ( ₹10.9B ) dépassent ses passifs à long terme ( ₹453.2M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: MOREPENLAB dispose de plus de liquidités que de sa dette totale.
Réduire la dette: Le ratio d'endettement de MOREPENLAB a été réduit de 64.2% à 3% au cours des 5 dernières années.
Couverture de la dette: La dette de MOREPENLAB est bien couverte par le flux de trésorerie opérationnel ( 144.2% ).
Couverture des intérêts: Les paiements d'intérêts de MOREPENLAB sur sa dette sont bien couverts par l'EBIT ( 65.5 x couverture).